Medical devices, healthcare technology and the business of care
510(k) clearance · K262842

BioFire Warrior Panel Control Kit

BioFire Defense, LLC · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONK262842

What did the FDA decide?

The FDA's 510(k) record K262842 covers the BioFire Warrior Panel Control Kit, submitted by BioFire Defense, LLC of Salt Lake City, Utah, with David Rabiger listed as applicant contact. The record places the submission under regulation number 866.392023 and the Microbiology specialty, with product code PMN. The listed receipt date is 08/12/2026.

The recorded decision is SESE, dated 2026-11-04. In 510(k) terms this denotes a substantially equivalent determination, meaning the control kit may be marketed on that basis; it is not a premarket approval of a new device. The record does not describe the kit's contents, its intended use, the predicate device, or any performance data, so those details remain unknown from this source.

The public record also does not state whether the submission was a traditional or abbreviated 510(k), nor does it identify any cleared device the kit is used with. Readers should treat the decision as a clearance determination for the named control kit only.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Microbiology
Decision date
Nov 4, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262842
Regulatory pathway
510(k) premarket notification
Product code
PMN
Decision code
SESE
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Assayed External Control Material For Microbiology Nucleic Acid Amplification (Nat) Assays.

Product code
PMN
FDA device class
2

FDA decision timeline

  1. K262842 received

    Application receipt date recorded by FDA.

  2. K262842 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code PMN

Product / regulatory recordCompanyPathwayDecision dateSource
Maine Molecular Quality Controls, Inc.510(k) clearanceOct 30, 2026FDA
Maine Molecular Quality Controls, Inc.510(k) clearanceOct 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

BioFire Defense, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Salt Lake City, UT

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records